Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function
NCT ID: NCT06819202
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1309 participants
OBSERVATIONAL
2025-06-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL.
The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hyperbaric Oxygen Therapy on Middle and Inner Ear Functions
NCT06209021
The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus
NCT05964725
Brain Mechanism and Outcome of Surgical Intervention of Conductive Hearing Loss.
NCT06535282
Vestibular Function and Vestibular Rehabilitation in SSHL With Vertigo
NCT03431506
A Multicenter Study of Noninvasive Neuromodulation Treatment for Subjective Tinnitus
NCT06727175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric oxygen treatment
HBO therapy is the process of inhaling 100% pure oxygen in an environment above one atmosphere (pressure range: 2.0-3.0 absolute atmospheres) to treat a disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-75 years old;
* Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.
Exclusion Criteria
* Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases;
* Pregnant and nursing patients;
* Accompanied by serious mental illness;
* Patients with incomplete clinical data.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yuting
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sun Yuting
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai University of Traditional Chinese Medicine
Shanghai, Putuo, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTEC-A-2025-1(S)-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.